Germany Approves First Medical Cannabis Cultivation License for No-Profit Organization

The German Federal Institute for Drugs and Medical Devices (BfArM) has granted the first medical cannabis cultivation license to a non-profit organization, the Association of Cannabis Medicine (ACM). This is a significant development for the German medical cannabis market, as it will allow for more diverse and affordable access to medical cannabis products.The German Federal Institute for Drugs and Medical Devices (BfArM) has granted the first medical cannabis cultivation license to a non-profit organization, the Association of Cannabis Medicine (ACM). This is a significant development for the German medical cannabis market, as it will allow for more diverse and affordable access to medical cannabis products.

The ACM is a non-profit organization that was founded in 2016 to promote the use of medical cannabis in Germany. The organization has been working to develop a cultivation license for several years, and the BfArM’s decision is a major victory for the group.

The ACM’s cultivation license will allow the organization to grow medical cannabis for use in its own products, as well as for sale to other pharmacies and clinics. The organization plans to use its profits to fund research into the medical benefits of cannabis and to provide education to healthcare professionals about the use of cannabis as a medicine.

The BfArM’s decision to grant a cultivation license to a non-profit organization is a departure from its previous policy of only granting licenses to for-profit companies. The decision is a sign that the BfArM is open to new approaches to the regulation of the medical cannabis market.

The ACM’s cultivation license is expected to have a significant impact on the German medical cannabis market. The organization’s non-profit status will allow it to offer its products at a lower cost than for-profit companies, and its focus on research and education will help to improve the understanding of the medical benefits of cannabis.

The granting of a cultivation license to the ACM is a positive development for the German medical cannabis market. It is a sign that the BfArM is open to new approaches to the regulation of the market, and it is likely to lead to more diverse and affordable access to medical cannabis products for patients.

The document was published on November 22, 2022. The sources are RNZ / Tess Brunton and RNZ Pacific.

You might be interested in exploring more about medical cannabis and its benefits. Speaking of medical cannabis, you might be interested in delving deeper into the topic by reading the Medical Cannabis article on Wikipedia. Additionally, if you want to learn about the regulations and policies surrounding medical cannabis in Germany, you can refer to the Cannabis in Germany Wikipedia article. These resources will provide you with further insights into the subject.

You might be interested in exploring more about medical cannabis and its benefits. Speaking of medical cannabis, you might be interested in delving deeper into the topic by reading the Medical Cannabis article on Wikipedia. Additionally, if you want to learn about the regulations and policies surrounding medical cannabis in Germany, you can refer to the Cannabis in Germany Wikipedia article. These resources will provide you with further insights into the subject.